These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 1726189

  • 1. Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue.
    Johnson MP, Huang XM, Nichols DE.
    Pharmacol Biochem Behav; 1991 Dec; 40(4):915-22. PubMed ID: 1726189
    [Abstract] [Full Text] [Related]

  • 2. Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue.
    Schmidt CJ, Wu L, Lovenberg W.
    Eur J Pharmacol; 1986 May 13; 124(1-2):175-8. PubMed ID: 2424776
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI, Green AR.
    Br J Pharmacol; 1994 Jan 13; 111(1):131-6. PubMed ID: 7516800
    [Abstract] [Full Text] [Related]

  • 5. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB.
    J Pharmacol Exp Ther; 1987 Sep 13; 242(3):911-6. PubMed ID: 2443644
    [Abstract] [Full Text] [Related]

  • 6. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.
    Battaglia G, Yeh SY, De Souza EB.
    Pharmacol Biochem Behav; 1988 Feb 13; 29(2):269-74. PubMed ID: 2452449
    [Abstract] [Full Text] [Related]

  • 7. Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat.
    O'Loinsigh ED, Boland G, Kelly JP, O'Boyle KM.
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr 13; 25(3):621-38. PubMed ID: 11371001
    [Abstract] [Full Text] [Related]

  • 8. Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate.
    Ali SF, Newport GD, Scallet AC, Binienda Z, Ferguson SA, Bailey JR, Paule MG, Slikker W.
    Neurotoxicol Teratol; 1993 Apr 13; 15(2):91-6. PubMed ID: 7685472
    [Abstract] [Full Text] [Related]

  • 9. Studies on the mechanism of p-chloroamphetamine neurotoxicity.
    Sprague JE, Johnson MP, Schmidt CJ, Nichols DE.
    Biochem Pharmacol; 1996 Oct 25; 52(8):1271-7. PubMed ID: 8937435
    [Abstract] [Full Text] [Related]

  • 10. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).
    Slikker W, Ali SF, Scallet AC, Frith CH, Newport GD, Bailey JR.
    Toxicol Appl Pharmacol; 1988 Jul 25; 94(3):448-57. PubMed ID: 2456631
    [Abstract] [Full Text] [Related]

  • 11. Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study.
    Gough B, Imam SZ, Blough B, Slikker W, Ali SF.
    Ann N Y Acad Sci; 2002 Jun 25; 965():410-20. PubMed ID: 12105116
    [Abstract] [Full Text] [Related]

  • 12. Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat.
    Galineau L, Belzung C, Kodas E, Bodard S, Guilloteau D, Chalon S.
    Brain Res Dev Brain Res; 2005 Feb 08; 154(2):165-76. PubMed ID: 15707670
    [Abstract] [Full Text] [Related]

  • 13. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration.
    Johnson MP, Nichols DE.
    Pharmacol Biochem Behav; 1989 May 08; 33(1):105-8. PubMed ID: 2476831
    [Abstract] [Full Text] [Related]

  • 14. Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain.
    O'Shea E, Esteban B, Camarero J, Green AR, Colado MI.
    Neuropharmacology; 2001 May 08; 40(1):65-74. PubMed ID: 11077072
    [Abstract] [Full Text] [Related]

  • 15. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.
    Sprague JE, Nichols DE.
    J Pharmacol Exp Ther; 1995 May 08; 273(2):667-73. PubMed ID: 7538579
    [Abstract] [Full Text] [Related]

  • 16. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
    Ricaurte GA, Martello AL, Katz JL, Martello MB.
    J Pharmacol Exp Ther; 1992 May 08; 261(2):616-22. PubMed ID: 1374470
    [Abstract] [Full Text] [Related]

  • 17. Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys.
    Kleven MS, Woolverton WL, Seiden LS.
    Brain Res; 1989 May 29; 488(1-2):121-5. PubMed ID: 2472850
    [Abstract] [Full Text] [Related]

  • 18. 2-Deoxy-D-glucose prevents and nicotinamide potentiates 3, 4-methylenedioxymethamphetamine-induced serotonin neurotoxicity.
    Hervías I, Lasheras B, Aguirre N.
    J Neurochem; 2000 Sep 29; 75(3):982-90. PubMed ID: 10936179
    [Abstract] [Full Text] [Related]

  • 19. Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate.
    Gough B, Ali SF, Slikker W, Holson RR.
    Pharmacol Biochem Behav; 1991 Jul 29; 39(3):619-23. PubMed ID: 1723797
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.